Clinical Trial Update: A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink. [Phase 1]

View source ↗

Summary

Phase 1 study in healthy men evaluating pharmacokinetics and tolerability of BI 474121 across doses and formulation (tablet vs. drink).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• BI 474121

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2024-03-26